Example of antiangiogenic, antivascular synergy between bevacizumab (Avastin) and tyrosine kinase inhibitors in a primary culture of human breast cancer
Synerg between bevacizumab and tyrosine kinase inhibitors


Method for testing antiangiogenic agents such as bevacizumab (Avastin) in primary cultures of fresh human tumor cells and peripheral blood